Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Silence Therapeutics (SLN) Return on Invested Capital (2024 - 2025)

Silence Therapeutics' Return on Invested Capital history spans 2 years, with the latest figure at 0.0% for Q4 2025.

  • On a quarterly basis, Return on Invested Capital changed 0.0% to 0.0% in Q4 2025 year-over-year; TTM through Dec 2025 was 0.0%, a 0.0% change, with the full-year FY2025 number at 0.0%, changed 0.0% from a year prior.
  • Return on Invested Capital hit 0.0% in Q4 2025 for Silence Therapeutics, up from 0.0% in the prior quarter.
  • Over the last five years, Return on Invested Capital for SLN hit a ceiling of 0.0% in Q4 2024 and a floor of 0.0% in Q3 2025.